Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 28,269 | 45,592 | 58,935 | 53,320 | 62,014 |
| Operating Income | -28,269 | -45,592 | -58,935 | -53,320 | -62,014 |
| Interest Expense | 815 | 809 | 799 | 834 | 877 |
| Other Income | 2,783 | 3,101 | 3,568 | 4,422 | 5,128 |
| Pre-tax Income | -26,301 | -43,300 | -56,166 | -49,732 | -57,763 |
| Net Income Continuous | -26,301 | -43,300 | -56,166 | -49,732 | -57,763 |
| Net Income | $-26,301 | $-43,300 | $-56,166 | $-49,732 | $-57,763 |
| EPS Basic Total Ops | -0.43 | -0.71 | -0.92 | -0.82 | -0.95 |
| EPS Basic Continuous Ops | -0.43 | -0.71 | -0.92 | -0.82 | -0.95 |
| EPS Diluted Total Ops | -0.43 | -0.71 | -0.92 | -0.82 | -0.95 |
| EPS Diluted Continuous Ops | -0.43 | -0.71 | -0.92 | -0.82 | -0.95 |
| EPS Diluted Before Non-Recurring Items | -0.43 | -0.71 | -0.92 | -0.82 | -0.95 |
| EBITDA(a) | $-27,498 | $-43,168 | $-57,125 | $-52,297 | $-60,481 |